UNSPSC 51282111: Penamecillin

This classification denotes a benzylpenicillin acetoxymethyl ester and penicillin g analog with the molecular formula C19H22N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0P1YE5581, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2s-(2alpha,5alpha,6beta))-, (acetyloxy)methyl ester but generally known as penamecillin, which bears US NIH Compound Identifier 13795.

UNSPSC 51282111 Penamecillin is a Commodity code that encompasses pharmaceutical products procured by state and local health agencies, though recent state and local activity under this code shows minimal direct alignment with the nominal scope. The two most recent opportunities associated with the code reflect broader pharmaceutical procurement rather than penamecillin specifically: the Illinois Department of Public Health awarded a piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, and Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems annually. State and local health departments and county public health bodies appear to be the primary issuing parties under pharmaceutical commodity codes, leveraging cooperative purchasing consortia such as MMCAP Infuse to aggregate demand and negotiate fixed-term contracts with renewal options.

Geographic activity is concentrated in Florida and Illinois based on recent postings. The Illinois Department of Public Health's award to Chartwell Rx LLC, posted August 28, 2026, represents a $2,999,999.11 contract across 12 months plus two renewal years procured through an Invitation for Bid process. Seminole County's IFB for Naloxone and Safe Drug Deactivation Systems, posted June 30, 2026, sought 1,900 units of Naloxone and 800 deactivation systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. The code shows limited recent solicitation activity overall, and the opportunities posted do not directly name penamecillin as a line item, suggesting either low current demand for the product within state and local procurement or potential miscoding of opportunities by issuing bodies.